78 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
on chronic Achilles tendinosis to be the first step in addressing other debilitating tendon injuries in the future,” concluded Dr. Davidson.
“The design … . It can result in ongoing pain and loss of function. Tendinosis is often caused by sports related injuries, occupational overuse, aging and poor general
6-K
REPCF
Replicel Life Sciences Inc.
1 May 13
Current report (foreign)
12:00am
the clinical development of a new autologous cell therapy for the treatment of a variety of chronic tendon injuries including Achilles, patellar and elbow … of chronic tendon injuries including Achilles, patellar and elbow. This technology is based on the Company’s core understanding of the unique biological
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
22 May 14
Current report (foreign)
12:00am
cell therapies that treat functional cellular deficits. RepliCel Tendon-01 (RCT-01) is a cell therapy for the treatment of chronic tendon injuries … deficits. RepliCel Tendon-01 (RCT-01) is a cell therapy for the treatment of chronic tendon injuries. RepliCel Hair-01 (RCH-01) is a cellular treatment
6-K
EX-99
r4ep510trale xqr
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
EX-99.1
w9odcbdjzdr733
6 Jun 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.1
0kcwri9vwoyrzwle53
9 Sep 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.1
5w0s04
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.1
eyt 62o5rw6moi84
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99.1
un8wlw
22 May 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.1
7q1 0tmxh7wcx
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99
nwfh7j
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
EX-99.2
xj4lbuur49e fvx63u6
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
q1s5thcrb
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.2
odese2rqkolr
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99
qnv8t
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
EX-99.2
tpy8yvqj
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.2
5ec8ap7n g2pa25
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
fncbg8tyvoz
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm